The test analyzes the levels of two proteins in the blood and has shown a link between these levels and patient outcomes. The pilot study showed that 98% of patients with low protein levels did not develop secondary breast cancer. The test could be ready for approval in two to three years.
Latest News
10:07
4 august 2026. TV: Ce s-a discutat aseară la televiziunile de știri
09:56
The Fuego volcano in Guatemala has erupted again: Authorities have declared a national alert.
09:46
Iran is one step away from attacking Ukraine. Why did the Islamic Republic change its mind at the last moment?
09:46
INHGA: The Danube flow at Baziaș will decrease to 1350 m³/s, below the historical minimum of 1400 m³/s
09:32
Radu Miruță, after the controlled explosion at Cernavodă: "Good news: at the nuclear power plant in Cernavodă, the water level has risen by 2cm compared to yesterday"
See more news